Evaluation of Pain and Discomfort in the Cardiac Catheterization Lab

February 1, 2023 updated by: Duke University

The purpose of this study is to explore how the timing of procedural sedation medications influences patient comfort and satisfaction with sedation.

Participation in this study will included be randomly assigned to one of two groups (long and short) within standard of care. Each group will observe a time interval between receiving procedural sedation medications and the start of the procedure. A trained observer will evaluate patient experience during the procedure and at the end of the procedure we will ask the participant 3 brief questions about the experience. All other information collected about the experience during the procedure will occur as part of usual care. No further activities will be asked as part of this study. All study activities will occur during a scheduled visit and participation is complete once questions have been answered.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

175

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult patients coming to Duke University for Cardiac Catheterization

Description

Inclusion Criteria:

  • English speaking
  • Coming to Duke University for Cardiac Catheterization

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Group 1- short interval
Less than or equal to six minutes between receiving sedation and the start of the procedure
Group 2- long interval
Greater than or equal to seven minutes between receiving sedation and the start of the procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total medication administration dosage as measured by the procedural database
Time Frame: During procedure, up to 2.5 hours
During procedure, up to 2.5 hours
Frequency of medication administration as measured by the procedural database
Time Frame: During procedure, up to 2.5 hours
During procedure, up to 2.5 hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Patient satisfaction as measured by Procedural Sedation Assessment Survey (PROSAS)
Time Frame: Within 2 hours of procedure
Within 2 hours of procedure
Pain as measured by observation using the Behavioral Pain Assessment Tool (BPAT)
Time Frame: During procedure, to 2.5 hours
During procedure, to 2.5 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Bradi Granger, PhD, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 7, 2020

Primary Completion (Actual)

April 30, 2021

Study Completion (Actual)

April 30, 2021

Study Registration Dates

First Submitted

July 24, 2020

First Submitted That Met QC Criteria

July 24, 2020

First Posted (Actual)

July 29, 2020

Study Record Updates

Last Update Posted (Actual)

February 3, 2023

Last Update Submitted That Met QC Criteria

February 1, 2023

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00102686

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Comfort

3
Subscribe